Suppr超能文献

2-硫代黄嘌呤是髓过氧化物酶的机制失活剂,可在炎症期间阻断氧化应激。

2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation.

机构信息

AstraZeneca R&D, Södertälje SE-151 85, Sweden.

出版信息

J Biol Chem. 2011 Oct 28;286(43):37578-89. doi: 10.1074/jbc.M111.266981. Epub 2011 Aug 31.

Abstract

Myeloperoxidase (MPO) is a prime candidate for promoting oxidative stress during inflammation. This abundant enzyme of neutrophils uses hydrogen peroxide to oxidize chloride to highly reactive and toxic chlorine bleach. We have identified 2-thioxanthines as potent mechanism-based inactivators of MPO. Mass spectrometry and x-ray crystal structures revealed that these inhibitors become covalently attached to the heme prosthetic groups of the enzyme. We propose a mechanism whereby 2-thioxanthines are oxidized, and their incipient free radicals react with the heme groups of the enzyme before they can exit the active site. 2-Thioxanthines inhibited MPO in plasma and decreased protein chlorination in a mouse model of peritonitis. They slowed but did not prevent neutrophils from killing bacteria and were poor inhibitors of thyroid peroxidase. Our study shows that MPO is susceptible to the free radicals it generates, and this Achilles' heel of the enzyme can be exploited to block oxidative stress during inflammation.

摘要

髓过氧化物酶 (MPO) 是炎症期间促进氧化应激的主要候选者。这种丰富的中性粒细胞酶利用过氧化氢将氯离子氧化成高反应性和毒性的次氯酸漂白剂。我们已经确定 2-硫代嘌呤是 MPO 的有效基于机制的失活剂。质谱和 X 射线晶体结构表明,这些抑制剂与酶的血红素辅基共价结合。我们提出了一种机制,其中 2-硫代嘌呤被氧化,它们的初始自由基在离开活性位点之前与酶的血红素基团反应。2-硫代嘌呤在血浆中抑制 MPO,并减少腹膜炎小鼠模型中的蛋白质氯化。它们减缓但不能阻止中性粒细胞杀死细菌,并且对甲状腺过氧化物酶的抑制作用较差。我们的研究表明,MPO 容易受到其产生的自由基的影响,而这种酶的致命弱点可以被利用来阻止炎症期间的氧化应激。

相似文献

1
2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation.
J Biol Chem. 2011 Oct 28;286(43):37578-89. doi: 10.1074/jbc.M111.266981. Epub 2011 Aug 31.
2
Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates.
J Biol Chem. 2013 Dec 20;288(51):36636-47. doi: 10.1074/jbc.M113.507756. Epub 2013 Nov 5.
3
Ceruloplasmin is an endogenous inhibitor of myeloperoxidase.
J Biol Chem. 2013 Mar 1;288(9):6465-77. doi: 10.1074/jbc.M112.418970. Epub 2013 Jan 10.
4
The development of myeloperoxidase inhibitors.
Bioorg Med Chem Lett. 2019 Jan 1;29(1):1-7. doi: 10.1016/j.bmcl.2018.11.031. Epub 2018 Nov 15.
5
Inactivation of myeloperoxidase by benzoic acid hydrazide.
Arch Biochem Biophys. 2015 Mar 15;570:14-22. doi: 10.1016/j.abb.2015.01.028. Epub 2015 Feb 14.
6
Roles of superoxide and myeloperoxidase in ascorbate oxidation in stimulated neutrophils and H2O2-treated HL60 cells.
Free Radic Biol Med. 2011 Oct 1;51(7):1399-405. doi: 10.1016/j.freeradbiomed.2011.06.029. Epub 2011 Jul 5.
8
Myricitrin as a substrate and inhibitor of myeloperoxidase: implications for the pharmacological effects of flavonoids.
Free Radic Biol Med. 2008 Jan 1;44(1):109-20. doi: 10.1016/j.freeradbiomed.2007.09.017. Epub 2007 Oct 6.
9
Inactivation of human myeloperoxidase by hydrogen peroxide.
Arch Biochem Biophys. 2013 Nov 1;539(1):51-62. doi: 10.1016/j.abb.2013.09.004. Epub 2013 Sep 11.
10
Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO).
Bioorg Med Chem. 2020 Jun 15;28(12):115548. doi: 10.1016/j.bmc.2020.115548. Epub 2020 May 12.

引用本文的文献

4
Dioxygenation of tryptophan residues by superoxide and myeloperoxidase.
J Biol Chem. 2025 Apr;301(4):108402. doi: 10.1016/j.jbc.2025.108402. Epub 2025 Mar 11.
5
Regulation of mammalian cellular metabolism by endogenous cyanide production.
Nat Metab. 2025 Mar;7(3):531-555. doi: 10.1038/s42255-025-01225-w. Epub 2025 Mar 3.
6
Myeloperoxidase as a therapeutic target for oxidative damage in Alzheimer's disease.
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2456282. doi: 10.1080/14756366.2025.2456282. Epub 2025 Feb 14.
8
Pharmacokinetics and Tolerability of the Novel Myeloperoxidase Inhibitor Mitiperstat in Healthy Japanese and Chinese Volunteers.
Clin Drug Investig. 2024 Nov;44(11):863-874. doi: 10.1007/s40261-024-01402-x. Epub 2024 Nov 4.
9
(Chemical) Roles of HOCl in Rheumatic Diseases.
Antioxidants (Basel). 2024 Jul 29;13(8):921. doi: 10.3390/antiox13080921.
10
Targeting Myeloperoxidase Ameliorates Gouty Arthritis: A Virtual Screening Success Story.
J Med Chem. 2024 Jul 25;67(14):12012-12032. doi: 10.1021/acs.jmedchem.4c00721. Epub 2024 Jul 11.

本文引用的文献

1
Myeloperoxidase: a key regulator of neutrophil oxidant production.
Redox Rep. 1997 Feb;3(1):3-15. doi: 10.1080/13510002.1997.11747085.
2
Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation.
J Biol Chem. 2011 Apr 15;286(15):12901-11. doi: 10.1074/jbc.M110.172460. Epub 2011 Jan 25.
3
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation.
Nat Med. 2010 Apr;16(4):470-4. doi: 10.1038/nm.2124. Epub 2010 Mar 21.
5
Reconciling the chemistry and biology of reactive oxygen species.
Nat Chem Biol. 2008 May;4(5):278-86. doi: 10.1038/nchembio.85.
6
Mammalian heme peroxidases: from molecular mechanisms to health implications.
Antioxid Redox Signal. 2008 Jul;10(7):1199-234. doi: 10.1089/ars.2007.1927.
7
How human neutrophils kill and degrade microbes: an integrated view.
Immunol Rev. 2007 Oct;219:88-102. doi: 10.1111/j.1600-065X.2007.00550.x.
8
Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction.
J Am Coll Cardiol. 2007 May 22;49(20):1993-2000. doi: 10.1016/j.jacc.2007.02.040. Epub 2007 May 4.
9
Reactions of superoxide with myeloperoxidase.
Biochemistry. 2007 Apr 24;46(16):4888-97. doi: 10.1021/bi602587k. Epub 2007 Mar 24.
10
Active site structure and catalytic mechanisms of human peroxidases.
Arch Biochem Biophys. 2006 Jan 15;445(2):199-213. doi: 10.1016/j.abb.2005.09.017. Epub 2005 Oct 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验